Tirzepatide activates two metabolic pathways — both GIP and GLP-1 receptors. In the SURMOUNT-1 trial of FDA-approved branded tirzepatide (Zepbound® 15 mg weekly), participants averaged a 20.9% body-weight reduction at 72 weeks. OPTML dispenses tirzepatide as a compounded preparation, prescribed by U.S.-licensed providers and filled by our 503A pharmacy partners.
SURMOUNT-1 studied FDA-approved branded tirzepatide, not compounded preparations. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.
Compounded medication is not FDA-approved. Starting at $349/mo · HSA/FSA eligible.
LegitScript CertifiedHealthcare Merchant
Prescription only
✓ Licensed US providers✓ 2-3 day discreet shipping✓ Cancel anytime
LegitScript CertifiedHealthcare Merchant
Tirzepatide is the only weight-loss molecule that activates two metabolic pathways — both GIP and GLP-1 receptors. In the SURMOUNT-1 trial of FDA-approved branded tirzepatide (Zepbound® 15 mg weekly), participants averaged a 20.9% body-weight reduction at 72 weeks. OPTML dispenses tirzepatide as a compounded preparation, prescribed by U.S.-licensed providers and filled by our licensed 503A pharmacy partners (Strive · Boothwyn · Absolute).
SURMOUNT-1 studied FDA-approved branded tirzepatide, not compounded preparations. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.
GLP-1 Muscle Loss Protocol included
Resistance-training program built around GLP-1 weight loss — because losing fat without muscle is the goal. No other compounded-GLP-1 provider includes this.
Starting at $349/mo · Free provider consult · HSA/FSA eligible
SURMOUNT-1 Trial · 72 weeks · Branded tirzepatide
In the SURMOUNT-1 trial of FDA-approved branded tirzepatide, participants averaged a 20.9% body-weight reduction over 72 weeks at the 15 mg weekly dose.*
*SURMOUNT-1 studied FDA-approved branded tirzepatide (Zepbound® 15 mg). Compounded preparations are not FDA-approved or evaluated by FDA. Individual results vary. Educational reference only.
Tirzepatide is a once-weekly injectable molecule that activates two metabolic receptors, GIP and GLP-1. In clinical trials of the FDA-approved branded preparations (Mounjaro® for type 2 diabetes; Zepbound® for chronic weight management, both manufactured by Eli Lilly), tirzepatide produced the largest average weight-loss effect of any GLP-1-class molecule studied to date.
The same molecule can also be prepared by licensed 503A compounding pharmacies as a personalized prescription. OPTML’s compounded tirzepatide is prescribed by U.S.-licensed providers and filled by our 503A pharmacy partners (Strive · Boothwyn · Absolute) under USP <797> sterility standards, then shipped to your door monthly. Compounded preparations are not FDA-approved or evaluated by FDA for safety, effectiveness, or quality.
Semaglutide (Ozempic, Wegovy) activates a single receptor: GLP-1. Tirzepatide activates two: GIP and GLP-1. The dual mechanism is why tirzepatide produces stronger weight loss in head-to-head data.
In SURMOUNT-5 (NEJM 2025), FDA-approved branded tirzepatide produced roughly 50% more weight loss than FDA-approved branded semaglutide over 72 weeks at maximum tolerated doses. The trial studied branded preparations, not compounded preparations.
Tirzepatide is for patients prioritizing maximum weight loss, who tolerate stronger appetite suppression, and who want the dual GIP/GLP-1 mechanism. In SURMOUNT-1, FDA-approved branded tirzepatide produced an average 20.9% body-weight reduction at 15 mg weekly over 72 weeks.
Semaglutide is for patients who want a gentler on-ramp, smaller doses, or have responded well to GLP-1-only therapy. In STEP-1, FDA-approved branded semaglutide produced an average 14.9% body-weight reduction at 2.4 mg weekly over 68 weeks.
Your OPTML provider helps you choose based on starting weight, tolerance, and goals.
SURMOUNT-1 (NEJM 2022, n=2,539) was the largest tirzepatide weight-loss trial ever run. At 72 weeks on the 15 mg dose, patients lost an average of 20.9% of body weight, with 91% losing at least 5%, and average waist reduction of 7.4 inches.
Source: Jastreboff AM et al. New England Journal of Medicine. SURMOUNT-1. 2022.
Two physician-led GLP-1 options for weight loss.
Clinical data based on SURMOUNT-1 and STEP 1. Compounded products are not FDA-approved.
No surprises, no upsells. Each shipment includes everything you need to administer safely at home, plus full clinical support.
The largest weight-loss outcome ever seen in a GLP-1 trial. 72-week randomized study, dosed to 15 mg.
Source: Jastreboff AM et al. New England Journal of Medicine. SURMOUNT-1 Trial. 2022.
Online assessment to first shipment in under a week. No in-person visits, no waiting rooms.
Start your free assessment →Answer a few questions about your health, weight history, and goals. Takes about 5 minutes online.
A U.S. licensed provider reviews your assessment and prescribes the right dose, if appropriate. You'll hear back from your provider.
If prescribed, your compounded tirzepatide, syringes, and supplies ship discreetly in 2-3 days. Free 2-3 day shipping always.
Self-administer at home. Most patients report reduced cravings and steady weight loss within 2-4 weeks.
Message your provider anytime. Dose adjustments, refills, and side-effect questions handled in-app. Cancel anytime.
Question 1 of 12
Start losing weight in 5 simple steps
Answer a few questions about your health, weight history, and goals — about 5 minutes, all online.
No commitment. No insurance needed. See full eligibility & contraindications →
Based on aggregate clinical-trial data (SURMOUNT-1, NEJM 2022). Individual results vary.
Most patients report reduced cravings and earlier fullness within the first two doses. Mild nausea is common; usually fades within a week.
By the end of month one, average reduction is 3-5% of body weight. Energy stabilizes. Provider checks in to titrate dose.
Average reduction reaches 7-10% by month three. Most patients are at full therapeutic dose by now. Body composition shifts; not just water.
By month six most reach 13-18% reduction. Appetite suppression is sustained. Maintenance dosing discussion begins around month nine.
Source: Jastreboff AM et al. NEJM 2022 (SURMOUNT-1, n=2,539, 72 weeks). 15 mg tirzepatide produced average −20.9% body weight reduction at 72 weeks vs −3.1% placebo.
$349/mo
Flat retail at every dose. No hidden tiers.
Compounded tirzepatide
The dual GIP/GLP-1 molecule, compounded by a licensed 503A pharmacy partner. Sterile multi-dose vials. Provider-titrated 2.5 → 15 mg. Compounded preparation; not FDA-approved.
U.S.-licensed provider
Your prescription is reviewed and managed by a licensed clinician. Dosing windows and titration coordinated to your response, not a generic protocol.
Direct provider access
Call or text your provider whenever you need to. Dose adjustments, side-effect questions, refills — handled in-thread.
All injection supplies
Sterile syringes, needles, and alcohol prep pads in every shipment. Sharps container included. No add-on charges, no surprise reorders.
Discreet 2-3 day shipping
Insulated, temperature-controlled, plain packaging. Always free, always tracked. Refrigerated stability instructions included.
503A-pharmacy compounded
Prepared by FDA-registered 503A pharmacies under USP <797> sterility standards. Every vial traceable, every batch tested.
Lab panels available as a separate add-on at member rates. HSA/FSA eligible. Cancel anytime.
Provider consult, compounded medication, syringes, and unlimited messaging, all included.
As your provider titrates your dose from 2.5 mg up to 15 mg, your monthly price never changes. No tier upgrades, no dose surcharges, no surprise bills.
Same price at every dose — 2.5 mg → 15 mg.
Your physician titrates your dose based on your response. Most patients reach the optimal therapeutic dose by month 4–5.
Your monthly price includes everything.
Physician consultation, prescription, and ongoing medical oversight. No hidden fees. No separate membership. Just your optml protocol.
Billed monthly. Cancel anytime.
Prescribed by board-certified U.S.-licensed clinicians
Licensed in all 50 states · Meet your care team
Free calculators and quizzes built around real clinical data. Use them as often as you want.
Goal date
When will you hit your goal weight?
GLP-1 cost
What you'll actually spend on GLP-1s this year
Savings
How much would you save with OPTML?
BMI
BMI & eligibility check
Match quiz
Find my protocol — match in 90 seconds
Deficit
Daily calorie deficit for your goal
TDEE
Total daily energy expenditure
BMR
Basal metabolic rate
Protein
Daily protein target for your goal
5-minute online consult. Provider review in 24 hours. First shipment in under a week.
LegitScript CertifiedHealthcare Merchant
5-minute online consult. Provider review in 24 hours. First shipment in under a week.